Meyka Pro banner
Zoetis Inc.

Zoetis Inc. (ZTS) Stock Overview

Explore Zoetis Inc.’s financial performance, market position, analyst ratings, and future outlook.

ZTSNYSE
HealthcareDrug Manufacturers - General
$75.35
$0.85(1.12%)
U.S. Market opens in 15h 32m

Zoetis Inc. (ZTS)

Meyka AI Score

Z

Key Financials

Market Cap31.6B
P/E Ratio12.58
EPS (TTM)$6.47
ROE0.62%
Fundamental Analysis

AI Price Forecasts

1 Month$73.21
3 Months$69.57
1 Year Target$80.77

ZTS Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Zoetis Inc. (ZTS) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 43.31, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $80.77.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 12.58 and a market capitalization of 31.6B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-1.14%
5-Day Change
-0.12%
1-Month Change
-0.74%
3-Month Change
-36.26%
6-Month Change
-39.77%
Year-to-Date (YTD) Change
-40.13%
1-Year Change
-48.88%
3-Year Change
-58.95%
5-Year Change
-61.96%
All-Time (Max) Change
142.92%

Contact Information

973 822 7000
10 Sylvan Way, Parsippany, NJ, 07054

Company Facts

145,000 Employees
IPO DateFeb 1, 2013
CountryUS
Actively Trading

Frequently Asked Questions